The discovery of "complementary" antibodies against plasminogen in patients with blood vessel inflammation caused by anti-neutrophil cytoplasmic autoantibodies may lead to new approaches to research, testing and treatment of ANCA vasculitis and other autoimmune diseases, suggests a new article.